04/11/2026
Around 95% of people with rare conditions don’t have access to a targeted treatment. If we continue with current approaches to medicines development, it could take thousands of years to reach every patient.
Our latest episode of Behind the Genes discussed how regulation needs to evolve to help more patients access treatments sooner, while ensuring safety remains central.
Listen on your favourite podcast platform, or on our website via the link in our bio.